Viehbacher Christopher

Track

Insider profile

Performance

Overall performance
2.9
Performance over holding periods
2.9
30 days 90 days 120 days
Average return 3% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
1 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Viehbacher Christopher's trades of Braveheart Bio, Inc.'s stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Purchase
Price
20.78
Quantity 22,616 +11.5%
Value US$2,374,025
FR Sanofi SA (SAN)
Transaction date
Purchase
Price
210.75
Quantity 80,888
Value €3,825,705
FR Sanofi SA (SAN)
Transaction date
Purchase
Price
342.11
Quantity 50,413
Value €909,225
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-08-07 2026-08-07
B Purchase
22,616 +11.5%
20.78
US$2,374,025 		22,616 +11.5% 20.78 US$2,374,025
2013-12-23 2013-12-18
FR Sanofi SA (SAN)
B Purchase
80,888
210.75
€3,825,705 		80,888 210.75 €3,825,705
2011-08-18 2011-08-11
FR Sanofi SA (SAN)
B Purchase
50,413
342.11
€909,225 		50,413 342.11 €909,225